What happens after my cancer stops responding to radioactive iodine?
Marcia Brose, MD, Director of Thyroid Cancer Therapeutics Program at Penn Medicine responds,
There are many new agents in clinical trials and some that might be available outside of clinical trials. In the last 5 years, many patients have had successful treatments. The first thing you should do is have a consultation with an oncologist who has experience treating advanced thyroid cancer. Ideally, if they are an active site in research they will have access to many promising new agents that you may be able to be treated with. Experience of the oncologist is very important so I would find out how many patients like you they treat in a year, and feel free to get more than one opinion. Think of it is doing research into your options and learning more about the disease, which will help you make the best decision for you.
This question and answer was part of OncoLink's Brown Bag Web Chat Series. View the entire transcript of Focus on Thyroid Cancer.
Oct 25, 2014 - A quantified alternative to the TNM system -- a cancer-staging system using tumor size, node involvement and presence of metastases -- provides a simple method of predicting recurrence and cancer-specific mortality, with no loss of discrimination compared to other systems, for differentiated thyroid carcinoma, according to research published online March 9 in the Journal of Clinical Oncology.
Oct 25, 2014
Oct 25, 2014